Asambly Chemicals Co. Ltd.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsLedipasvir Intermediates

1256387 74 2 Ledipasvir Intermediates C18H22BrN3O2 cGMP standard

I'm Online Chat Now

1256387 74 2 Ledipasvir Intermediates C18H22BrN3O2 cGMP standard

China 1256387 74 2 Ledipasvir Intermediates C18H22BrN3O2 cGMP standard supplier

Large Image :  1256387 74 2 Ledipasvir Intermediates C18H22BrN3O2 cGMP standard

Product Details:

Place of Origin: China
Certification: Meet with cGMP standard

Payment & Shipping Terms:

Minimum Order Quantity: 1KG
Packaging Details: Drum
Contact Now
Detailed Product Description
Usage: Ledipasvir Intermediates CAS: 1256387-74-2
Molecular Formula: C18H22BrN3O2
High Light:

1129634 44 1

,

1441670 89 8

CAS : 1256387-74-2 Ledipasvir Intermediate C18H22BrN3O2 cGMP standard

 

Chemical Name : ( 1R  ,3S , 4S ) - 3 - ( 6 - Bromo - 1H - benzimidazol - 2 - yl ) - 2 - azabicyclo [ 2 . 2 . 1 ] heptane - 2 - carboxylic acid 1 , 1 -dimethylethyl ester

 

CAS No . : 1256387-74-2

 

Molecular Formula : C18H22BrN3O2

 

Molecular Weight : 392.29

 

Usage : Ledipasvir Intermediate

 

Description :

 

Ledipasvir developped by Gilead Sciences is used to treat Hepatitis C. Ledipasvir is a inhibitor of a hepatitis C virus protein called NS5A. It is used together with another drug called Sofosbuvir. The fixed dose - combination tablet Ledipasvir / Sofosbuvir was approved by US FDA in February 10 , 2014 . The brand name of the combination product Ledipasvir / Sofosbuvir is Harvoni. It is used for genotpye 1 Hepatitis C.

 

( 1R ,3S , 4S ) - 3 - ( 6 - Bromo - 1H - benzimidazol - 2 - yl ) - 2 - azabicyclo [ 2 . 2 . 1 ] heptane - 2 - carboxylic acid 1 , 1 -dimethylethyl ester CAS No . : 1256387-74-2 is one of its intermediates. There are several synthesis routes to manufacture this intermediate but some routes are protected by the patents in some countries including Europe, USA and China. We strictly obey the laws and our commercial products are manufactured without infringing such patents. But anyway, the buyers should know the patent status by themselves. We promise to supply the real route of synthesis to the buyers. The buyers should take the risks of patent infringement by themselves.

 

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.

 

Contact Details
Asambly Chemicals Co. Ltd.

Contact Person: MAO Xiaolong

Send your inquiry directly to us (0 / 3000)